Takayasu's arteritis: An update on physiopathology

European Journal of Internal Medicine

Volumn 17, Issue 4, 2006, Pages 241-246

  Arnaud, Laurent ^a   Kahn, Jean Emmanuel ^a   Girszyn, Nicolas ^a   Piette, Anne Marie ^a   Bletry, Olivier ^a  

^a FOCH HOSPITAL   (France)

Author keywords

Immunology; Physiopathology; T cell; Takayasu's arteritis

Indexed keywords

AUTOANTIGEN; CHEMOKINE; CORTICOSTEROID; CYTOKINE; ENDOTHELIAL CELL ANTIBODY; EPITOPE; HEAT SHOCK PROTEIN 60; IMMUNOSUPPRESSIVE AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1 RELATED CHAIN A; MATRIX METALLOPROTEINASE; NATURAL KILLER CELL RECEPTOR NKG2D; PROTEIN DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG;

AORTA; AORTA ARCH SYNDROME; ARTERY WALL; B LYMPHOCYTE; BLOOD VESSEL INJURY; CELL INFILTRATION; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; ENDOTHELIUM CELL; HUMAN; HUMORAL IMMUNITY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MONONUCLEAR CELL; NATURAL KILLER CELL; NONHUMAN; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REMISSION; REVIEW; T LYMPHOCYTE;

EID: 33744534468     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2005.12.002     Document Type: Review

References (57)

1. Clinical and pathological studies of aortitis syndrome. Committee report. Jpn Heart J 9 1 (1968) 76-87
2. Lupi-Herrera E., Sanchez-Torres G., Marcushamer J., Mispireta J., Horwitz S., and Vela J.E. Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 93 1 (1977) 94-103
3. Noris M. Physiopathology of Takayasu's arteritis. J Nephrol 14 6 (2001) 506-513
4. Seko Y., Minota S., Kawasaki A., Shinkai Y., Maeda K., Yagita H., et al. Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis. J Clin Invest 93 2 (1994) 750-758
5. Flores-Dominguez C., Hernandez-Pacheco G., Zuniga J., Gamboa R., Granados J., Reyes P.A., et al. Alleles of the major histocompatibility system associated with susceptibility to the development of Takayasu's arteritis. Gac Med Mex 138 2 (2002) 177-183
6. Vargas-Alarcon G., Hernandez-Pacheco G., Soto M.E., Murguia L.E., Perez-Hernandez N., Granados J., et al. Comparative study of the residues 63 and 67 on the HLA-B molecule in patients with Takayasu's Arteritis. Immunol Lett 96 2 (2005) 225-229
7. Yoshida M., Kimura A., Katsuragi K., Numano F., and Sasazuki T. DNA typing of HLA-B gene in Takayasu's arteritis. Tissue Antigens 42 2 (1993) 87-90
8. Seko Y., Sato O., Takagi A., Tada Y., Matsuo H., Yagita H., et al. Restricted usage of T-cell receptor Valpha-Vbeta genes in infiltrating cells in aortic tissue of patients with Takayasu's arteritis. Circulation 93 10 (1996) 1788-1790
9. Seko Y., Takahashi N., Tada Y., Yagita H., Okumura K., and Nagai R. Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 75 Suppl 1 (2000) S77-S83 [discussion S85-7]
10. Sagar S., Ganguly N.K., Koicha M., and Sharma B.K. Immunophysiopathology of Takayasu arteritis. Heart Vessels Suppl 7 (1992) 85-90
11. Nityanand S., Giscombe R., Srivastava S., Hjelmstrom P., Sanjeevi C.B., Sinha N., et al. A bias in the alphabeta T cell receptor variable region gene usage in Takayasu's arteritis. Clin Exp Immunol 107 2 (1997) 261-268
12. Dhar J., Ganguly N.K., Kumari S., and Sharma B.K. Role of calcium and protein kinase C in the activation of T cells in Takayasu's arteritis. Jpn Heart J 36 3 (1995) 341-348
13. Scott D.G., Salmon M., Scott D.L., Blann A., Bacon P.A., Walton K.W., et al. Takayasu's arteritis: a pathogenetic role for cytotoxic T lymphocytes?. Clin Rheumatol 5 4 (1986) 517-522
14. Schultz D.R., and Arnold P.I. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Semin Arthritis Rheum 22 6 (1993) 357-374
15. Aggarwal A., Chag M., Sinha N., and Naik S. Takayasu's arteritis: role of Mycobacterium tuberculosis and its 65 kDa heat shock protein. Int J Cardiol 55 1 (1996) 49-55
16. Moraes M.F., Ordway D., Oliveira L., Costa I.L., Badura R., Pinheiro M.N., et al. Cellular immune responses to Mycobacterium tuberculosis in a patient with Takayasu's arteritis. Rev Port Cardiol 18 4 (1999) 359-367
17. Kumar Chauhan S., Kumar Tripathy N., Sinha N., Singh M., and Nityanand S. Cellular and humoral immune responses to mycobacterial heat shock protein-65 and its human homologue in Takayasu's arteritis. Clin Exp Immunol 138 3 (2004) 547-553
18. Bertipaglia B., Faggin E., Cillo U., Zanus G., Angelini A., and Pauletto P. Is apoptosis of vascular smooth muscle cells involved in the development of Takayasu arteritis? Suggestions from a case report. Rheumatology (Oxford) 44 4 (Apr 2004) 484-487
19. Seko Y., Sugishita K., Sato O., Takagi A., Tada Y., Matsuo H., et al. Expression of costimulatory molecules (4-1BBL and Fas) and major histocompatibility class I chain-related A (MICA) in aortic tissue with Takayasu's arteritis. J Vasc Res 41 1 (2004) 84-90
20. Vinay D.S., and Kwon B.S. Role of 4-1BB in immune responses. Semin Immunol 10 6 (1998) 481-489
21. Wen T., Bukczynski J., and Watts T.H. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function. J Immunol 168 10 (2002) 4897-4906
22. Smyth M.J., Cretney E., Kelly J.M., Westwood J.A., Street S.E., Yagita H., et al. Activation of NK cell cytotoxicity. Mol Immunol 42 4 (2005) 501-510
23. Bauer S., Groh V., Wu J., Steinle A., Phillips J.H., Lanier L.L., et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285 5428 (1999) 727-729
24. Hotchi M. Pathological studies on Takayasu arteritis. Heart Vessels Suppl 7 (1992) 11-17
25. Noguchi S., Numano F., Gravanis M.B., and Wilcox J.N. Increased levels of soluble forms of adhesion molecules in Takayasu arteritis. Int J Cardiol 66 Suppl 1 (1998) S23-S33 [discussion S35-6]
26. Inder S.J., Bobryshev Y.V., Cherian S.M., Wang A.Y., Lord R.S., Masuda K., et al. Immunophenotypic analysis of the aortic wall in Takayasu's arteritis: involvement of lymphocytes, dendritic cells and granulocytes in immuno-inflammatory reactions. Cardiovasc Surg 8 2 (2000) 141-148
27. Inder S.J., Bobryshev Y.V., Cherian S.M., Lord R.S., Masuda K., and Yutani C. Accumulation of lymphocytes, dendritic cells, and granulocytes in the aortic wall affected by Takayasu's disease. Angiology 51 7 (2000) 565-579
28. Krupa W.M., Dewan M., Jeon M.S., Kurtin P.J., Younge B.R., Goronzy J.J., et al. Trapping of misdirected dendritic cells in the granulomatous lesions of giant cell arteritis. Am J Pathol 161 5 (2002) 1815-1823
29. Okada M., Kitahara M., Kishimoto S., Matsuda T., Hirano T., and Kishimoto T. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells. J Immunol 141 5 (1988) 1543-1549
30. Luger T.A., Krutmann J., Kirnbauer R., Urbanski A., Schwarz T., Klappacher G., et al. IFN-beta 2/IL-6 augments the activity of human natural killer cells. J Immunol 143 4 (1989) 1206-1209
31. Kishimoto T. Interleukin-6 and its receptor in autoimmunity. J Autoimmun 5 Suppl A (1992) 123-132
32. Schall T.J., Bacon K., Toy K.J., and Goeddel D.V. Selective attraction of monocytes and T lymphocytes of the memory phenotype by cytokine RANTES. Nature 347 6294 (1990) 669-671
33. Noris M., Daina E., Gamba S., Bonazzola S., and Remuzzi G. Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions?. Circulation 100 1 (1999) 55-60
34. Tripathy N.K., Sinha N., and Nityanand S. Interleukin-8 in Takayasu's arteritis: plasma levels and relationship with disease activity. Clin Exp Rheumatol 22 6 Suppl 36 (2004) S27-S30
35. Matsuyama A., Sakai N., Ishigami M., Hiraoka H., Kashine S., Hirata A., et al. Matrix metalloproteinases as novel disease markers in Takayasu arteritis. Circulation 108 12 (2003) 1469-1473
36. Tripathy N.K., Chauhan S.K., and Nityanand S. Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 138 2 (2004) 369-374
37. Hoffman G.S., Merkel P.A., Brasington R.D., Lenschow D.J., and Liang P. Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 50 7 (2004) 2296-2304
38. Gyotoku Y., Kakiuchi T., Nonaka Y., Saito Y., Ito I., and Murao S. Immune complexes in Takayasu's arteritis. Clin Exp Immunol 45 2 (1981) 246-252
39. Eichhorn J., Sima D., Thiele B., Lindschau C., Turowski A., Schmidt H., et al. Anti-endothelial cell antibodies in Takayasu arteritis. Circulation 94 10 (1996) 2396-2401
40. Ito I. Aortitis syndrome with reference to the detection of antiaorta antibody from patients' sera. Jpn Circ J 30 (1966) 75-79
41. Ito I., Saito Y., and Nonaka Y. Immunological aspects of aortitis syndrome. Jpn Circ J 39 4 (1975) 459-462
42. Nakao K., Ikeda M., Kimata S., Niitani H., and Niyahara M. Takayasu's arteritis. Clinical report of eighty-four cases and immunological studies of seven cases. Circulation 35 6 (1967) 1141-1155
43. Ueda H., Ito I., and Saito Y. Autoantibodies in cardiovascular disease. Jpn J Clin Med 22 (1964) 1271-1278
44. Chopra P., Datta R.K., Dasgupta A., and Bhargava S. Non specific aortoarteritis (Takayasu's disease). An immunologic and autopsy study. Jpn Heart J 24 4 (1983) 549-556
45. Dhingra R., Talwar K.K., Chopra P., and Kumar R. An enzyme linked immunosorbent assay for detection of anti-aorta antibodies in Takayasu arteritis patients. Int J Cardiol 40 3 (1993) 237-242
46. Dhingra R., Chopra P., Talwar K.K., and Kumar R. Enzyme-linked immunosorbent assay and immunoblot study in Takayasu's arteritis patients. Indian Heart J 50 4 (1998) 428-432
47. Baltazares M., Mendoza F., Dabague J., and Reyes P.A. Antiaorta antibodies and Takayasu arteritis. Int J Cardiol 66 Suppl 1 (1998) S183-S187 [discussion S189]
48. Tripathy N.K., Upadhyaya S., Sinha N., and Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 28 4 (2001) 805-808
49. Misra R., Aggarwal A., Chag M., Sinha N., and Shrivastava S. Raised anticardiolipin antibodies in Takayasu's arteritis. Lancet 343 8913 (1994) 1644-1645
50. Yokoi K., Akaike M., Shigekiyo T., and Saito S. An elderly patient with Takayasu's arteritis associated with antiphospholipid antibodies. Nippon Ronen Igakkai Zasshi 31 9 (1994) 716-719
51. Yokoi K., Hosoi E., Akaike M., Shigekiyo T., and Saito S. Takayasu's arteritis associated with antiphospholipid antibodies. Report of two cases. Angiology 47 3 (1996) 315-319
52. Nava A., Senecal J.L., Banales J.L., Raymond I., and Reyes P.A. Absence of antiphospholipid/co-factor antibodies in Takayasu arteritis. Int J Cardiol 75 Suppl 1 (2000) S99-S104
53. Nityanand S., Mishra K., Shrivastava S., Holm G., and Lefvert A.K. Autoantibodies against cardiolipin and endothelial cells in Takayasu's arteritis: prevalence and isotype distribution. Br J Rheumatol 36 8 (1997) 923-924
54. Uppal S.S., and Verma S. Analysis of the clinical profile, autoimmune phenomena and T cell subsets (CD4 and CD8) in Takayasu's arteritis: a hospital-based study. Clin Exp Rheumatol 21 6 Suppl 32 (2003) S112-S116
55. Tripathy N.K., Sinha N., and Nityanand S. Anti-annexin V antibodies in Takayasu's arteritis: prevalence and relationship with disease activity. Clin Exp Immunol 134 2 (2003) 360-364
56. Tripathy N.K., Sinha N., and Nityanand S. Antimonocyte antibodies in Takayasu's arteritis: prevalence of and relation to disease activity. J Rheumatol 30 9 (2003) 2023-2026
57. Liang P., and Hoffman G.S. Advances in the medical and surgical treatment of Takayasu arteritis. Curr Opin Rheumatol 17 1 (2005) 16-24